Evidence map›Paper›PMID 28115349›Full record

ArticleAntimicrobial agents and chemotherapy2017

Survival of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 in Human Blood.

Frank R DeLeo, Scott D Kobayashi, Adeline R Porter, Brett Freedman, David W Dorward, Liang Chen, Barry N Kreiswirth

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. TARGETING THE CAPSULE OFbioRxiv : the preprint server for biology · 2026
    Article
  3. Differential virulence potential of different clades of multidrug-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
  4. Connections betweenInfection and immunity · 2026
    Article
  5. Targeting the capsule ofFrontiers in immunology · 2026
    Article
  6. mBio · 2025
    Article
  7. Multidrug-resistant hypervirulentFuture microbiology · 2025
    Review
  8. Article
  9. The Influence of Carbohydrates on the Virulence Potential ofInternational journal of microbiology · 2025
    Article
  10. Vaccines · 2024
    Review
  11. Article
  12. Heliyon · 2024
    Article
  13. Hypervirulent Capsular Serotypes K1 and K2International journal of molecular sciences · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Frank R DeLeoLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA fdeleo@niaid.nih.gov.
Scott D KobayashiLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Adeline R PorterLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Brett FreedmanLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
David W DorwardResearch Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Liang ChenPublic Health Research Institute Tuberculosis Center, New Jersey Medical School-Rutgers University, Newark, New Jersey, USA.
Barry N KreiswirthPublic Health Research Institute Tuberculosis Center, New Jersey Medical School-Rutgers University, Newark, New Jersey, USA.
National Institutes of Health · USRutgers, The State University of New Jersey · USNational Institute of Allergy and Infectious Diseases · US

Funding

Basis for Success of Multidrug-Resistant EnterobacteriaceaeZIAAI001195 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DELEO, FRANK · 2014 to 2025
$11.9M
The molecular basis of the epidemic blaKPC gene KlebsiellaR01AI090155 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KREISWIRTH, BARRY NEAL · 2011 to 2021
$7.2M
Genomic variation in epidemic carbapenem-resistant K.pneumoniaeR21AI117338 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI CHEN, LIANG · 2016 to 2017
$437k
NIAID NIH HHS R01 AI090155NIAID NIH HHS R21 AI117338
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Bacterial AgentsBacteremiaCarbapenemsDisease Models, AnimalHumansKlebsiella pneumoniaeMiceMice, Inbred BALB CMultilocus Sequence TypingVirulenceAnti-Bacterial AgentsCarbapenemsantibiotic resistancebactericidal activitybloodstream infectionscarbapenem resistancecomplementKlebsiella pneumoniae

Identifiers

PMID28115349
PMCPMC5365663
OpenAlexW2618579708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.